XML 65 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Data (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Summary of Net Sales and Other Information by Segment

Net sales and other information by segment is as follows (in millions):

 

 

 

Net Sales

 

 

Operating Profit (Loss)

 

 

Depreciation and Amortization

 

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021

 

 

2020

 

 

2019

 

 

2021

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Americas Orthopedics

 

$

4,102.1

 

 

$

3,699.5

 

 

$

4,148.8

 

 

$

1,709.3

 

 

$

1,528.2

 

 

$

1,831.8

 

 

$

143.1

 

 

$

135.6

 

 

$

126.6

 

EMEA

 

 

1,533.8

 

 

 

1,288.6

 

 

 

1,623.1

 

 

 

392.7

 

 

 

308.9

 

 

 

484.0

 

 

 

74.4

 

 

 

77.5

 

 

 

77.0

 

Asia Pacific

 

 

1,318.3

 

 

 

1,256.9

 

 

 

1,323.8

 

 

 

429.4

 

 

 

420.5

 

 

 

472.7

 

 

 

74.6

 

 

 

71.3

 

 

 

65.3

 

Americas Spine and Global Dental

 

 

882.0

 

 

 

779.5

 

 

 

886.5

 

 

 

136.0

 

 

 

105.6

 

 

 

150.9

 

 

 

26.0

 

 

 

32.7

 

 

 

35.6

 

Total

 

$

7,836.2

 

 

$

7,024.5

 

 

$

7,982.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Functions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(632.2

)

 

 

(754.1

)

 

 

(750.9

)

 

 

133.6

 

 

 

118.0

 

 

 

117.3

 

Inventory and manufacturing-related charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(41.8

)

 

 

(54.2

)

 

 

(53.9

)

 

 

-

 

 

 

-

 

 

 

-

 

Intangible asset amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(615.7

)

 

 

(597.6

)

 

 

(584.3

)

 

 

615.7

 

 

 

597.6

 

 

 

584.3

 

Goodwill and intangible asset impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16.3

)

 

 

(645.0

)

 

 

(70.1

)

 

 

-

 

 

 

-

 

 

 

-

 

Restructuring and other cost reduction initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(130.5

)

 

 

(116.9

)

 

 

(50.0

)

 

 

-

 

 

 

-

 

 

 

-

 

Quality remediation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(53.2

)

 

 

(49.8

)

 

 

(87.6

)

 

 

-

 

 

 

-

 

 

 

-

 

Acquisition, integration, divestiture and related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(81.8

)

 

 

(23.8

)

 

 

(12.2

)

 

 

-

 

 

 

-

 

 

 

-

 

Litigation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(192.9

)

 

 

(159.8

)

 

 

(65.0

)

 

 

-

 

 

 

-

 

 

 

-

 

Litigation settlement gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

23.5

 

 

 

-

 

 

 

-

 

 

 

-

 

European Union Medical Device Regulation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(46.5

)

 

 

(25.3

)

 

 

(30.9

)

 

 

-

 

 

 

-

 

 

 

-

 

Certain R&D agreements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(65.0

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Other charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11.4

)

 

 

(24.5

)

 

 

(120.5

)

 

 

-

 

 

 

-

 

 

 

-

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

$

780.1

 

 

$

(87.8

)

 

$

1,137.5

 

 

$

1,067.4

 

 

$

1,032.7

 

 

$

1,006.1

 

 
Disclosure on Geographic Areas, Long-Lived Assets

We conduct business in the following countries that hold 10 percent or more of our total consolidated Property, plant and equipment, net (in millions):

 

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

United States

 

$

1,212.6

 

 

$

1,252.6

 

Other countries

 

 

803.9

 

 

 

795.1

 

Property, plant and equipment, net

 

$

2,016.5

 

 

$

2,047.7